Researchers Explore Hydrogels That Are Promising Materials For Delivering Therapeutic Cells – Texas A&M University

Electron micrograph showing ridges and grooves on MAP hydrogel microbeads caused by developing stem cells.

Courtsey of Daniel Alge

Baby diapers, contact lenses and gelatin dessert. While seemingly unrelated, these items have one thing in common theyre made of highly absorbent substances called hydrogels that have versatile applications. Recently, a type of biodegradable hydrogel, dubbed microporous annealed particle (MAP) hydrogel, has gained much attention for its potential to deliver stem cells for body tissue repair. But it is currently unclear how these jelly-like materials affect the growth of their precious cellular cargo, thereby limiting its use in regenerative medicine.

In a new study published in the November issue of Acta Biomaterialia, researchers at Texas A&M University have shown that MAP hydrogels, programmed to biodegrade at an optimum pace, create a fertile environment for bone stem cells to thrive and proliferate vigorously. They found the space created by the withering of MAP hydrogels creates room for the stem cells to grow, spread and form intricate cellular networks.

Our research now shows that stem cells flourish on degrading MAP hydrogels; they also remodel their local environment to better suit their needs, said Daniel Alge, assistant professor in the Department of Biomedical Engineering. These results have important implications for developing MAP hydrogel-based delivery systems, particularly for regenerative medicine where we want to deliver cells that will replace damaged tissues with new and healthy ones.

MAP hydrogels are a newer breed of injectable hydrogels. These soft materials are interconnected chains of extremely small beads made of polyethylene glycol, a synthetic polymer. Although the microbeads cannot themselves cling to cells, they can be engineered to present cell-binding proteins that can then attach to receptor molecules on the stem cells surface.

Once fastened onto the microbeads, the stem cells use the space between the spheres to grow and transform into specialized cells, like bone or skin cells. And so, when there is an injury, MAP hydrogels can be used to deliver these new cells to help tissues regenerate.

However, the health and behavior of stem cells within the MAP hydrogel environment has never been fully studied.

MAP hydrogels have superior mechanical and biocompatible properties, so in principle, they are a great platform to grow and maintain stem cells, Alge said. But people in the field really dont have a good understanding of how stem cells behave in these materials.

To address this question, the researchers studied the growth, spread and function of bone stem cells in MAP hydrogels. Alge and his team used three samples of MAP hydrogels that differed only in the speed at which they degraded, that is, either slow, fast or not at all.

First, for the stem cells to attach onto the MAP hydrogels, the researchers decorated the MAP hydrogels with a type of cell-binding protein. They then tracked the stem cells as they grew using a high-resolution, fluorescent microscope. The researchers also repeated the same experiment using another cell-binding protein to investigate if cell-binding proteins also affected stem cell development within the hydrogels.

To their surprise, Alges team found that for both types of cell-binding proteins, the MAP hydrogels that degraded the fastest had the largest population of stem cells. Furthermore, the cells were changing the shape of the MAP hydrogel as they spread and claimed more territory.

In the intact MAP hydrogel, we could still see the spherical microbeads and the material was quite undamaged, Alge said. By contrast, the cells were making ridges and grooves in the degrading MAP hydrogels, dynamically remodeling their environment.

The researchers also found that as the stem cells grew, the quantity of bone proteins produced by the growing stem cells depended on which cell-binding protein was initially used in the MAP hydrogel.

Alge noted that the insight gained through their study will greatly inform further research and development in MAP hydrogels for stem-cell therapies.

Although MAP hydrogel degradability profoundly affects the growth of the stem cells, we found that the interplay between the cell-binding proteins and the degradation is also important, he said. As we, as a field, make strides toward developing new MAP hydrogels for tissue engineering, we must look at the effects of both degradability and cell-binding proteins to best utilize these materials for regenerative medicine.

Other contributors to the research include Shangjing Xin from the Department of Biomedical Engineering at Texas A&M and Carl A. Gregory from the Institute for Regenerative Medicine at the Texas A&M Health Science Center.

This research was supported by funds from theNational Institute of Arthritis and Musculoskeletal and Skin Diseasesof the National Institutes of Health.

Link:
Researchers Explore Hydrogels That Are Promising Materials For Delivering Therapeutic Cells - Texas A&M University

Gill Aviation to Help Fund Blood Cancer Research – AviationPros.com

Gill Aviation has initiated a week-long campaign to raise awareness and help fund blood cancer research by donating a portion of fuel sales to the Leukemia & Lymphoma Society (LLS).

From February 3-7, Gill Aviation will donate 5 cents for every gallon of Jet A fuel sold. In addition, donations can be made on-line through a special LLS web page created by Kya Gill, a Houston, Texas high school student, in honor of her sister Paige who underwent treatment for Lymphoma. The goal is to raise $250,000 during the campaign period.

We are very proud of our daughter Kya and her efforts to help fund blood cancer research to fight Leukemia and Lymphoma, two of the most common forms of cancer in children, teens and young adults, said Jag Gill, President of Gill Aviation. We have selected to work with LLS because the research they do provides a gateway to curing these cancers through advanced treatments such as chemotherapy, radiation and stem cell transplantation.

Read the original here:
Gill Aviation to Help Fund Blood Cancer Research - AviationPros.com

Two Day Conference on Cell Therapy Bioprocessing (Boston, MA, United States – June 25-26, 2020) – Gain Insight into the Latest Advancements and…

DUBLIN, Feb. 4, 2020 /PRNewswire/ -- The "2nd Annual Cell Therapy Bioprocessing Conference" conference has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Over the last decade, the field of cell therapy has rapidly grown, and it holds enormous promise for treating many diseases. There are factors like manufacturing maze, investment, logistics and regulatory challenges which prevents cell and gene therapies being widely used.

A unique platform to provide the exact solutions to these robust manufacturing and bioprocessing challenges is presented at the 2nd Annual Cell Therapy Bioprocessing Conference, taking place at Boston-USA on 25th & 26th June 2020.

Key Highlights

Why Attend

Who Should Attend:

From Therapeutics and Pharmaceuticals, Cell & Gene therapy-based companies:

Engineers/ Scientists/ Researchers/ Project leaders in:

Agenda:

Day 1: Thursday June 25th

CELL CULTURE TO CELL THERAPY

CELL THERAPY BIOPROCESSING AND DEVELOPMENT

PROCESS MONITORING & QUALITY CONTROL

Day 2: Friday June 26th

LOGISTICS, REGULATORY & INVESTMENT

Speakers:

For more information about this conference visit https://www.researchandmarkets.com/r/z4ezsr

About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/two-day-conference-on-cell-therapy-bioprocessing-boston-ma-united-states---june-25-26-2020---gain-insight-into-the-latest-advancements-and-opportunities-in-the-cell-gene-therapy-manufacturing-area-300998633.html

SOURCE Research and Markets

The rest is here:
Two Day Conference on Cell Therapy Bioprocessing (Boston, MA, United States - June 25-26, 2020) - Gain Insight into the Latest Advancements and...

Global Viral Inactivation Market Analysis 2016 to 2026 – Market Expected to Reach $1,209.17 Million by 2026 – ResearchAndMarkets.com – Yahoo Finance

The "Global Viral Inactivation Market Analysis 2019" report has been added to ResearchAndMarkets.com's offering.

The Viral Inactivation market is expected to reach $1,209.17 million by 2026 growing at a CAGR of 14.2% from 2018 to 2026.

Factors such as increasing government support for pharmaceutical and biotechnology industries, an increase in the number of drug launches & approvals and rising investment in the life sciences sector are driving the market growth. Though, high cost of biologics and biosimilar products development & manufacturing restrain the market growth.

Based on the product, Kits and reagents are expected to have a lucrative growth during the forecast period due to their continuous usage by pharmaceutical and biopharmaceutical companies. With an increase in the number of pharmaceutical and biopharmaceutical companies and the rise in R&D spending for the purpose of new drug development, the usage of kits and reagents has increased tremendously.

Key Questions Answered in this Report:

The key vendors mentioned are Merck KGAA, Cerus Corporation, Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation, Texcell, Inc., Parker Hannifin Corporation, Sanofi SA, SGS SA, Invitrogen Corp., General Electric Co., Rad Source Technologies, Qiagen NV, ZeptoMetrix Corp., MockV Solutions, Vironova AB, Viral Inactivated Plasma Systems SA, and BioReliance.

Key Questions Answered in this Report:

Key Topics Covered:

1 Market Synopsis

2 Research Outline

2.1 Research Snapshot

2.2 Research Methodology

2.3 Research Sources

2.3.1 Primary Research Sources

2.3.2 Secondary Research Sources

3 Market Dynamics

3.1 Drivers

3.2 Restraints

4 Market Environment

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Viral Inactivation Market, By Product

5.1 Introduction

5.2 Services

5.3 Viral Inactivation Systems and Accessories

5.4 Kits and Reagents

6 Global Viral Inactivation Market, By Method

6.1 Introduction

6.2 Pasteurization

6.3 Solvent Detergent Method

6.4 Other Methods

7 Global Viral Inactivation Market, By Application

7.1 Introduction

7.2 Blood and Blood Products

7.3 Tissues and Tissue Products

7.4 Vaccines and Therapeutics

7.5 Stem Cell Products

7.6 Cellular and Gene Therapy Products

8 Global Viral Inactivation Market, By End User

8.1 Introduction

8.2 Pharmaceutical and Biotechnology Companies

8.3 Academic Research Institutes

8.4 Contract Research Organizations

8.5 Blood Banks and Hospitals

9 Global Viral Inactivation Market, By Geography

9.1 Introduction

9.2 North America

9.3 Europe

9.4 Asia Pacific

9.5 South America

9.6 Middle East & Africa

10 Strategic Benchmarking

11 Vendors Landscape

11.1 Merck KGAA

11.2 Cerus Corporation

11.3 Thermo Fisher Scientific Inc.

11.4 Sartorius AG

11.5 Danaher Corporation

11.6 Texcell, Inc.

11.7 Parker Hannifin Corporation

11.8 Sanofi SA

11.9 SGS SA

11.10 Invitrogen Corp.

11.11 General Electric Co.

11.12 Rad Source Technologies

11.13 Qiagen NV

11.14 ZeptoMetrix Corp.

11.15 MockV Solutions

11.16 Vironova AB

11.17 Viral Inactivated Plasma Systems SA

11.18 BioReliance

For more information about this report visit https://www.researchandmarkets.com/r/m0wcqb

View source version on businesswire.com: https://www.businesswire.com/news/home/20200204005900/en/

Contacts

ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900

Follow this link:
Global Viral Inactivation Market Analysis 2016 to 2026 - Market Expected to Reach $1,209.17 Million by 2026 - ResearchAndMarkets.com - Yahoo Finance

Biologics Safety Testing Market Will Be Hit $ 4.8 Billion By 2026 – Story of Future

The global Biologics Safety Testing Market is anticipated to grow at a constant CAGR around 11.7% from 2019 to 2026 and the market value reach around US$ 4.8 billion by 2026.

According to a new report by Acumen Research and Consulting, Recently published report titled Biologics Safety Testing Market Global Industry Analysis, Market Size, Opportunities and Forecast, 2019-2026. This report also covers details of market size, growth spectrum, and the competitive scenario of the Biologics Safety Testing Market in the forecast era.

Recent global market survey Biologics Safety Testing Market involves various industry organizations from different geographies to generate a report of more than 100 pages. The study is an optimal combination of quality and quantitative data which illustrates major market trends, challenges facing by industry and company, as well as gap analysis and new opportunities with trends on this market. The research links historical data for 2015-2018 and forecasts up to 2026. The objective of this research is to present an application; type and geographical region evaluation of the worldwide Biologics Safety Testing Market Regions include North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa.

Click To Get>>>FREE SAMPLE PDF (Including Full TOC, Table & Figures)

Biologics Safety Testing Market (By Product Type: Kits & Reagents, Instruments; By Application: Blood and Blood-related Products Testing, Vaccine and Therapeutics Development, Cellular and Gene Therapy, Tissue and Tissue-related Products Testing, Stem Cell Research; By Test Type: Endotoxin Tests, Sterility Tests, Cell Line Authentication and Characterization Tests, Residual Host Contamination Detection Tests, Adventitious Agent Detection Tests, Bioburden tests, Other) Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 2026

The research is also aimed at delivering the recent market intelligence and helping decision makers make sound investment evaluations, as well as defining and analysing changing trends and key drivers, challenges & opportunities. We have also implemented significant company rivals who penetrate the global Biologics Safety Testing Market with major strategies and competitive landscape to evaluate the situation of players currently. The study also identifies the qualitative effect on market segmentation and geographical regions of distinct market variables. Thus, the research builds the attractiveness of each important segment over the forecast period.

This research includes a thorough 360-degree analysis on this market, which provides insight into possibilities and difficulties for the stakeholders. It monitors the worldwide Biologics Safety Testing Market in developed economies and provides detailed comment and precise quantitative insight. The research also involves incisive competitive landscape analyses and offers important market players suggestions on effective imperatives and strategies.

Scope of the Report:

The report first uses historic data from different companies. The data collected is used to analyses the growth of industries in the past years. It includes data from the year 2015 to the year 2018. The forecast data provides the reader with an understating of the future of the market. The same data is used to predict the expectation of the companies and how they are expected to evolve in the coming years. The research provides historical as well as estimated data from the year 2019 to 2026. The details in the report give a brief overview of the market by examining its historical data, the current data, and forecast data to understand the growth of the market.

Competitive Landscape

The competition witnessed in the market is soaring. With rising demand for innovation, players are experimenting with various strategies to gain competitive edge and strengthen their foothold in the market. Several companies operating in the industry are looking at expanding their footprint across emerging nations to capitalize on the prevailing opportunities there. The gap in demand and supply of healthcare facilities in underdeveloped countries has resulted in the presence of unmet demand in these countries. These companies are looking at capitalizing on this to emerge at the fore of the global market.

Growth strategies adopted by the companies operating in the market are examined in detail. This is done to study how these strategies influence on this market. Furthermore, the bargaining power of suppliers and buyers. Furthermore, it reveals threat from new entrants and available substitute products.

Key Players & Strategies

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market. The Biologics Safety Testing Market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues.

Some major players in the Intelligent Intravenous Infusion Pumps Market include Charles River Laboratories, SGS SA, Lonza Group LTD, Merck KGaA, and WuXi Apptec, Thermo Fisher Scientific Inc., Sartorius AG, Cytovance Biologics, Inc., Pace Analytical Services Inc., Eurofins Scientific Se, Avance Biosciences Inc., Source Bioscience, and Toxikon Corporation among others.

Market Segmentation

Market By Product Type

Market By Application

Market By Test Type

Market By Geography

Key Takeaways:

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com| +1 407 915 4157

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW1.1. Definition and Scope1.1.1. Definition of Biologics Safety Testing1.1.2. Market Segmentation1.1.3. List of Abbreviations1.2. Summary1.2.1. Market Snapshot1.2.2. Biologics Safety Testing Market By Application1.2.2.1. Global Biologics Safety Testing Market Revenue and Growth Rate Comparison By Application (2015-2026)1.2.2.2. Global Biologics Safety Testing Market Revenue Share By Application in 20171.2.2.3. Vaccine and Therapeutics Development1.2.2.4. Blood and Blood-related Products Testing1.2.2.5. Cellular and Gene Therapy1.2.2.6. Tissue and Tissue-related Products Testing1.2.2.7. Stem Cell Research1.2.3. Biologics Safety Testing Market By Product Type1.2.3.1. Global Biologics Safety Testing Market Revenue and Growth Rate Comparison By Product Type (2015-2026)1.2.3.2. Global Biologics Safety Testing Market Revenue Share By Product Type in 20171.2.3.3. Kits & Reagents1.2.3.4. Instruments1.2.4. Biologics Safety Testing Market By Test Type1.2.4.1. Global Biologics Safety Testing Market Revenue and Growth Rate Comparison By Test Type (2015-2026)1.2.4.2. Global Biologics Safety Testing Market Revenue Share By Test Type in 20171.2.4.3. Sterility Tests1.2.4.4. Endotoxin Tests1.2.4.5. Cell Line Authentication and Characterization Tests1.2.4.6. Residual Host Contamination Detection Tests1.2.4.7. Adventitious Agent Detection Tests1.2.4.8. Bioburden tests1.2.4.9. Others1.2.5. Biologics Safety Testing Market By Geography1.2.5.1. Global Biologics Safety Testing Market Revenue and Growth Rate Comparison by Geography (2015-2026)1.2.5.2. North America Biologics Safety Testing Market Revenue and Growth Rate (2015-2026)1.2.5.3. Europe Biologics Safety Testing Market Revenue and Growth Rate (2015-2026)1.2.5.4. Asia-Pacific Biologics Safety Testing Market Revenue and Growth Rate (2015-2026)1.2.5.5. Latin America Biologics Safety Testing Market Revenue and Growth Rate (2015-2026)1.2.5.6. Middle East and Africa (MEA) Biologics Safety Testing Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS2.1. Market Drivers2.2. Restraints and Challenges2.3. Growth Opportunities2.4. Porters Five Forces Analysis2.4.1. Bargaining Power of Suppliers2.4.2. Bargaining Power of Buyers2.4.3. Threat of Substitute2.4.4. Threat of New Entrants2.4.5. Degree of Competition2.5. Value Chain Analysis2.6. Cost Structure Analysis2.6.1. Raw Material and Suppliers2.6.2. Manufacturing Process Analysis2.7. Regulatory Compliance2.8. Competitive Landscape, 20172.8.1. Player Positioning Analysis2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS3.1. Capacity and Commercial Production Date of Global Biologics Safety Testing Major Manufacturers in 20173.2. Manufacturing Plants Distribution of Global Biologics Safety Testing Major Manufacturers in 20173.3. R&D Status and Technology Source of Global Biologics Safety Testing Major Manufacturers in 20173.4. Raw Materials Sources Analysis of Global Biologics Safety Testing Major Manufacturers in 2017

CHAPTER 4. BIOLOGICS SAFETY TESTING MARKET BY APPLICATION4.1. Global Biologics Safety Testing Revenue By Application4.2. Vaccine and Therapeutics Development4.2.1. Market Revenue and Growth Rate, 2015 2026 ($Million)4.2.2. Market Revenue and Forecast, By Region, 2015 2026 ($Million)4.3. Blood and Blood-related Products Testing4.3.1. Market Revenue and Growth Rate, 2015 2026 ($Million)4.3.2. Market Revenue and Forecast, By Region, 2015 2026 ($Million)4.4. Cellular and Gene Therapy4.4.1. Market Revenue and Growth Rate, 2015 2026 ($Million)4.4.2. Market Revenue and Forecast, By Region, 2015 2026 ($Million)4.5. Tissue and Tissue-related Products Testing4.5.1. Market Revenue and Growth Rate, 2015 2026 ($Million)4.5.2. Market Revenue and Forecast, By Region, 2015 2026 ($Million)4.6. Stem Cell Research4.6.1. Market Revenue and Growth Rate, 2015 2026 ($Million)4.6.2. Market Revenue and Forecast, By Region, 2015 2026 ($Million)

CHAPTER 5. BIOLOGICS SAFETY TESTING MARKET BY PRODUCT TYPE5.1. Global Biologics Safety Testing Revenue By Product Type5.2. Kits & Reagents5.2.1. Market Revenue and Growth Rate, 2015 2026 ($Million)5.2.2. Market Revenue and Forecast, By Region, 2015 2026 ($Million)5.3. Instruments5.3.1. Market Revenue and Growth Rate, 2015 2026 ($Million)5.3.2. Market Revenue and Forecast, By Region, 2015 2026 ($Million)

CHAPTER 6. BIOLOGICS SAFETY TESTING MARKET BY TEST TYPE6.1. Global Biologics Safety Testing Revenue By Test Type6.2. Sterility Tests6.2.1. Market Revenue and Growth Rate, 2015 2026 ($Million)6.2.2. Market Revenue and Forecast, By Region, 2015 2026 ($Million)6.3. Endotoxin Tests6.3.1. Market Revenue and Growth Rate, 2015 2026 ($Million)6.3.2. Market Revenue and Forecast, By Region, 2015 2026 ($Million)6.4. Cell Line Authentication and Characterization Tests6.4.1. Market Revenue and Growth Rate, 2015 2026 ($Million)6.4.2. Market Revenue and Forecast, By Region, 2015 2026 ($Million)6.5. Residual Host Contamination Detection Tests6.5.1. Market Revenue and Growth Rate, 2015 2026 ($Million)6.5.2. Market Revenue and Forecast, By Region, 2015 2026 ($Million)6.6. Adventitious Agent Detection Tests6.6.1. Market Revenue and Growth Rate, 2015 2026 ($Million)6.6.2. Market Revenue and Forecast, By Region, 2015 2026 ($Million)6.7. Bioburden tests6.7.1. Market Revenue and Growth Rate, 2015 2026 ($Million)6.7.2. Market Revenue and Forecast, By Region, 2015 2026 ($Million)6.8. Others6.8.1. Market Revenue and Growth Rate, 2015 2026 ($Million)6.8.2. Market Revenue and Forecast, By Region, 2015 2026 ($Million)

CHAPTER 7. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET BY COUNTRY7.1. North America Biologics Safety Testing Market Revenue and Growth Rate, 2015 2026 ($Million)7.2. North America Biologics Safety Testing Market Revenue Share Comparison, 2015 & 2026 (%)7.3. U.S.7.3.1. U.S. Biologics Safety Testing Market Revenue and Forecast By Application, 2015 2026 ($Million)7.3.2. Market Revenue and Forecast By Product Type, 2015 2026 ($Million)7.3.3. Market Revenue and Forecast By Test Type, 2015 2026 ($Million)7.4. Canada7.4.1. Market Revenue and Forecast By Application, 2015 2026 ($Million)7.4.2. Market Revenue and Forecast By Product Type, 2015 2026 ($Million)7.4.3. Market Revenue and Forecast By Test Type, 2015 2026 ($Million)

CHAPTER 8. EUROPE BIOLOGICS SAFETY TESTING MARKET BY COUNTRY8.1. Europe Biologics Safety Testing Market Revenue and Growth Rate, 2015 2026 ($Million)8.2. Europe Biologics Safety Testing Market Revenue Share Comparison, 2015 & 2026 (%)8.3. UK8.3.1. Market Revenue and Forecast By Application, 2015 2026 ($Million)8.3.2. Market Revenue and Forecast By Product Type, 2015 2026 ($Million)8.3.3. Market Revenue and Forecast By Test Type, 2015 2026 ($Million)8.4. Germany8.4.1. Market Revenue and Forecast By Application, 2015 2026 ($Million)8.4.2. Market Revenue and Forecast By Product Type, 2015 2026 ($Million)8.4.3. Market Revenue and Forecast By Test Type, 2015 2026 ($Million)8.5. France8.5.1. Market Revenue and Forecast By Application, 2015 2026 ($Million)8.5.2. Market Revenue and Forecast By Product Type, 2015 2026 ($Million)8.5.3. Market Revenue and Forecast By Test Type, 2015 2026 ($Million)8.6. Spain8.6.1. Market Revenue and Forecast By Application, 2015 2026 ($Million)8.6.2. Market Revenue and Forecast By Product Type, 2015 2026 ($Million)8.6.3. Market Revenue and Forecast By Test Type, 2015 2026 ($Million)8.7. Rest of Europe8.7.1. Market Revenue and Forecast By Application, 2015 2026 ($Million)8.7.2. Market Revenue and Forecast By Product Type, 2015 2026 ($Million)8.7.3. Market Revenue and Forecast By Test Type, 2015 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET BY COUNTRY9.1. Asia-Pacific Biologics Safety Testing Market Revenue and Growth Rate, 2015 2026 ($Million)9.2. Asia-Pacific Biologics Safety Testing Market Revenue Share Comparison, 2015 & 2026 (%)9.3. China9.3.1. Market Revenue and Forecast By Application, 2015 2026 ($Million)9.3.2. Market Revenue and Forecast By Product Type, 2015 2026 ($Million)9.3.3. Market Revenue and Forecast By Test Type, 2015 2026 ($Million)9.4. Japan9.4.1. Market Revenue and Forecast By Application, 2015 2026 ($Million)9.4.2. Market Revenue and Forecast By Product Type, 2015 2026 ($Million)9.4.3. Market Revenue and Forecast By Test Type, 2015 2026 ($Million)9.5. India9.5.1. Market Revenue and Forecast By Application, 2015 2026 ($Million)9.5.2. Market Revenue and Forecast By Product Type, 2015 2026 ($Million)9.5.3. Market Revenue and Forecast By Test Type, 2015 2026 ($Million)9.6. Australia9.6.1. Market Revenue and Forecast By Application, 2015 2026 ($Million)9.6.2. Market Revenue and Forecast By Product Type, 2015 2026 ($Million)9.6.3. Market Revenue and Forecast By Test Type, 2015 2026 ($Million)9.7. South Korea9.7.1. Market Revenue and Forecast By Application, 2015 2026 ($Million)9.7.2. Market Revenue and Forecast By Product Type, 2015 2026 ($Million)9.7.3. Market Revenue and Forecast By Test Type, 2015 2026 ($Million)9.8. Rest of Asia-Pacific9.8.1. Market Revenue and Forecast By Application, 2015 2026 ($Million)9.8.2. Market Revenue and Forecast By Product Type, 2015 2026 ($Million)9.8.3. Market Revenue and Forecast By Test Type, 2015 2026 ($Million)

CHAPTER 10. LATIN AMERICA BIOLOGICS SAFETY TESTING MARKET BY COUNTRY10.1. Latin America Biologics Safety Testing Market Revenue and Growth Rate, 2015 2026 ($Million)10.2. Latin America Biologics Safety Testing Market Revenue Share Comparison, 2015 & 2026 (%)10.3. Brazil10.3.1. Market Revenue and Forecast By Application, 2015 2026 ($Million)10.3.2. Market Revenue and Forecast By Product Type, 2015 2026 ($Million)10.3.3. Market Revenue and Forecast By Test Type, 2015 2026 ($Million)10.4. Mexico10.4.1. Market Revenue and Forecast By Application, 2015 2026 ($Million)10.4.2. Market Revenue and Forecast By Product Type, 2015 2026 ($Million)10.4.3. Market Revenue and Forecast By Test Type, 2015 2026 ($Million)10.5. Rest of Latin America10.5.1. Market Revenue and Forecast By Application, 2015 2026 ($Million)10.5.2. Market Revenue and Forecast By Product Type, 2015 2026 ($Million)10.5.3. Market Revenue and Forecast By Test Type, 2015 2026 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET BY COUNTRY11.1. Middle East & Africa Biologics Safety Testing Market Revenue and Growth Rate, 2015 2026 ($Million)11.2. Middle East & Africa Biologics Safety Testing Market Revenue Share Comparison, 2015 & 2026 (%)11.3. GCC11.3.1. Market Revenue and Forecast By Application, 2015 2026 ($Million)11.3.2. Market Revenue and Forecast By Product Type, 2015 2026 ($Million)11.3.3. Market Revenue and Forecast By Test Type, 2015 2026 ($Million)11.4. Saudi Africa11.4.1. Market Revenue and Forecast By Application, 2015 2026 ($Million)11.4.2. Market Revenue and Forecast By Product Type, 2015 2026 ($Million)11.4.3. Market Revenue and Forecast By Test Type, 2015 2026 ($Million)11.5. Rest of Middle East & Africa11.5.1. Market Revenue and Forecast By Application, 2015 2026 ($Million)11.5.2. Market Revenue and Forecast By Product Type, 2015 2026 ($Million)11.5.3. Market Revenue and Forecast By Test Type, 2015 2026 ($Million)

CHAPTER 12. COMPANY PROFILE12.1. Charles River Laboratories12.1.1. Company Snapshot12.1.2. Overview12.1.3. Financial Overview12.1.4. Product Portfolio12.1.5. Key Developments12.1.6. Strategies12.2. SGS SA12.2.1. Company Snapshot12.2.2. Overview12.2.3. Financial Overview12.2.4. Product Portfolio12.2.5. Key Developments12.2.6. Strategies12.3. Lonza Group LTD12.3.1. Company Snapshot12.3.2. Overview12.3.3. Financial Overview12.3.4. Product Portfolio12.3.5. Key Developments12.3.6. Strategies12.4. Merck KGaA12.4.1. Company Snapshot12.4.2. Overview12.4.3. Financial Overview12.4.4. Product Portfolio12.4.5. Key Developments12.4.6. Strategies12.5. WuXi Apptec12.5.1. Company Snapshot12.5.2. Overview12.5.3. Financial Overview12.5.4. Product Portfolio12.5.5. Key Developments12.5.6. Strategies12.6. Thermo Fisher Scientific Inc.12.6.1. Company Snapshot12.6.2. Overview12.6.3. Financial Overview12.6.4. Product Portfolio12.6.5. Key Developments12.6.6. Strategies12.7. Sartorius AG12.7.1. Company Snapshot12.7.2. Overview12.7.3. Financial Overview12.7.4. Product Portfolio12.7.5. Key Developments12.7.6. Strategies12.8. Cytovance Biologics, Inc.12.8.1. Company Snapshot12.8.2. Overview12.8.3. Financial Overview12.8.4. Product Portfolio12.8.5. Key Developments12.8.6. Strategies12.9. Pace Analytical Services Inc.12.9.1. Company Snapshot12.9.2. Overview12.9.3. Financial Overview12.9.4. Product Portfolio12.9.5. Key Developments12.9.6. Strategies12.10. Eurofins Scientific Se12.10.1. Company Snapshot12.10.2. Overview12.10.3. Financial Overview12.10.4. Product Portfolio12.10.5. Key Developments12.10.6. Strategies12.11. Avance Biosciences Inc.12.11.1. Company Snapshot12.11.2. Overview12.11.3. Financial Overview12.11.4. Product Portfolio12.11.5. Key Developments12.11.6. Strategies12.12. Source Bioscience12.12.1. Company Snapshot12.12.2. Overview12.12.3. Financial Overview12.12.4. Product Portfolio12.12.5. Key Developments12.12.6. Strategies12.13. Toxikon Corporation12.13.1. Company Snapshot12.13.2. Overview12.13.3. Financial Overview12.13.4. Product Portfolio12.13.5. Key Developments12.13.6. Strategies12.14. Others12.14.1. Company Snapshot12.14.2. Overview12.14.3. Financial Overview12.14.4. Product Portfolio12.14.5. Key Developments12.14.6. Strategies

CHAPTER 13. RESEARCH APPROACH13.1. Research Methodology13.1.1. Initial Data Search13.1.2. Secondary Research13.1.3. Primary Research13.2. Assumptions and Scope

Buy this Premium Research Report@https://www.acumenresearchandconsulting.com/buy-now/0/1656

The report is readily available and can be dispatched immediately after payment confirmation.

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Contact Us:

Saurabh S.Phone: +14079154157 | +14089009135Email: sales@acumenresearchandconsulting.comWebsite:https://www.acumenresearchandconsulting.comFollow Us:LinkedIN |Twitter

See more here:
Biologics Safety Testing Market Will Be Hit $ 4.8 Billion By 2026 - Story of Future